Muscle Mass and Grip Strength Predict Fatty Liver Risk: Epidemiological Observations
Lower muscle mass and grip strength are associated with a higher risk of incident non-alcoholic fatty liver disease (NAFLD), highlighting the importance of muscle health in metabolic regulation and the prevention of hepatic steatosis.
August 2022
T Cells from Common Colds and SARS-CoV-2 Infection: Implications for Vaccine Development
Findings on T cells from common colds and SARS-CoV-2 infection provide valuable insights for developing second-generation universal vaccines, highlighting the potential for cross-reactive immunity against diverse coronavirus strains.
August 2022
Link Between Bone Marrow Activity and Heart Disease: Insights into Inflammation
Greater buildup of white blood cells in the bone marrow drives inflammation, contributing to the pathogenesis of heart disease and arterial inflammation, highlighting the interconnectedness of bone marrow activity and cardiovascular health.
August 2022
Thrombophilia Testing in the Era of Direct Oral Anticoagulants: Clinical Recommendations
Thrombophilia testing should be done selectively in patients receiving direct oral anticoagulants, with general agreement among clinicians on the need for individualized risk assessment and tailored management strategies based on patient-specific factors and clinical indications.
August 2022
Weight Loss and Colorectal Adenoma Risk Reduction: Clinical Implications
Weight loss may reduce the risk of developing colorectal adenoma, offering potential preventive strategies to mitigate the risk of colorectal cancer precursor lesions and promote colorectal health in at-risk individuals.
August 2022
COVID-19 Vaccine and Menstrual Cycle: Study Findings on Pfizer and Moderna Vaccines
Most vaccinated individuals experienced a small increase in menstrual cycle length, with the Pfizer and Moderna vaccines being the most commonly received, shedding light on potential menstrual cycle changes following COVID-19 vaccination.
August 2022
